Galderma’s newest hyaluronic acid lip filler, Restylane Kysse, is more than meets the eye. We sat down with Alisa Lask, general manager and vice president of the U.S. Aesthetic Business at Galderma, to find out exactly what the latest filler on the market has to offer. Spoiler alert: it’s a lot.
A smaller amount of filler is required
Findings from Galderma’s multi-phase study were surprising—the filler was found to last up to a year, for one—but the most shocking finding, according to Lask, didn’t have to do with longevity. “The results that surprised us most came from the Phase 3 head-to-head study that showed a significantly lower amount of Restylane Kysse was needed to show an improvement in lip fullness when compared to the control filler (1.82mL vs. 2.24mL),” she explains.
The results are a crowd-pleaser
Lask says another interesting finding came from the brand’s Phase 4 study, which revealed that 90-percent of patients’ partners were satisfied with the results of Restylane Kysse treatment. “We know from market research that patients can be reluctant to get lip injections because they are concerned with partner satisfaction, so we are thrilled with this finding.”
Kysse is the first FDA-approved lip filler to use XpresHAn Technology
While Lask explains Restylane Refyne and Defyne, both approved for laugh lines, are formulated with XpresHAn Technology—a manufacturing process which Lask says allows for a gel that “integrates into the skin for natural expression in motion” versus a firmer, more structured look—Restylane Kysse is the first and only FDA-approved lip filler to harness the technology. The result? A plush, pillowy look, as seen in the below brand-supplied photos.
Originally published on April 10, 2020
Now more than ever, we’re all for celebrating the things that bring us joy and a tiny bit of escape. The latest to add to the list? FDA’s approval of a brand new lip filler from medical giant Galderma: Restylane Kysse, a hyaluronic acid filler designed specifically for a softer, plumper pout.
What makes this new-on-the-block option different from the rest of Restylane’s hyaluronic acid fillers? According to New York dermatologist Joshua Zeichner, MD, it’s the unique cross-linking technology that gives the substance a balance between structure and flexibility. “Its structure offers versatility of use across different patient needs, allowing us to treat both structure and fullness of the lips with one product.”
“Restylane Kysse was specifically designed for the lips and has particles that are smaller than some of the other products,” adds West Palm Beach, FL dermatologist Kenneth Beer, MD, whose South-Florida practice was a clinical-trial site for the new filler.
While Kysse is not yet commercially available, Dr. Zeichner notes that, according to clinical studies, the filler’s effects were shown to last up to one year—a welcome jump from the typical six-to-nine-month period many HA fillers tend to stick around for. In fact, Galderma shared that 78-percent of trial patients reported they were still satisfied with their results after one year. “This will be especially helpful for patients who have a low pain tolerance for injections or those who are unable to get to the office as frequently as they would like,” adds Dr. Zeichner.
You May Also Like
According to the FDA, the filler was approved “for injection into the lips for lip augmentation and for correction of upper perioral rhytids in patients over the age of 21.”
However, unwelcome timing doesn’t go unnoticed. “The approval during a pandemic is less than optimal,” notes Dr. Beer. “However, I still have patients making appointments for when life resumes.” Dr. Zeichner adds: “All of our health efforts are focusing on controlling the COVID-19 pandemic right now. My hope is that one day soon, we will be in a place where we can begin to think of elective procedures again.”
“We are working to determine the appropriate launch timing and availability for Restylane Kysse,” read Galderma’s latest press release. “The health and safety of aesthetic providers, patients and Galderma employees is our utmost priority and will continue to be.” Stay tuned to NewBeauty.com for updates.
This story was originally published on April 10, 2020 and has since been updated.